Clinical Trial Update: The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

View source ↗

Summary

A completed clinical trial compares safety and effectiveness of warfarin versus apixaban in patients with end-stage kidney disease on dialysis who have non-valv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease
• Non-valvular Atrial Fibrillation
• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Abu Dhabi Health Services Company | Conditions: End-Stage Kidney Disease (ESKD), Non-valvular Atrial Fibrillation (NVAF) | Status: COMPLETED